Results 191 to 200 of about 31,041 (297)

Choice of Antiplatelet vs. Anticoagulant for Blunt Cerebrovascular Injury. [PDF]

open access: yesLife (Basel)
Baloi D   +7 more
europepmc   +1 more source

Clinical risk phenotypes in diabetes and their associations with adverse cardiovascular events: A report from the Silesia Diabetes‐Heart Project

open access: yesDiabetic Medicine, EarlyView.
Abstract Aims Diabetes is characterized by clinical heterogeneity. This study aimed to identify different clinical phenotypes of real‐world people with diabetes and to assess their associations with major adverse cardiovascular events (MACEs). Methods From a prospective Polish registry of people with diabetes, hierarchical cluster analysis was ...
Marta Mantovani   +13 more
wiley   +1 more source

Comparative cardiovascular risk of sulfonylureas with low‐ and high‐affinities for cardiac mitochondrial adenosine triphosphate‐sensitive potassium channels versus dipeptidyl peptidase‐4 inhibitors in patients with type 2 diabetes: A cohort study

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
Abstract Aims To individually evaluate the cardiovascular safety of low‐ and high‐affinity cardiac mitochondrial ATP‐sensitive potassium (mitoKATP) channel sulfonylureas by comparing each to dipeptidyl peptidase‐4 inhibitors (DPP‐4i), a generally cardiovascular‐neutral comparator, given prior evidence suggesting greater cardiovascular risk with high ...
Mei‐Hsiu Chen   +8 more
wiley   +1 more source

An interpretable machine learning model for predicting metabolic dysfunction‐associated steatotic liver disease in patients with type 2 diabetes

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
Abstract Aim Patients with type 2 diabetes mellitus (T2DM) exhibit an elevated prevalence of metabolic dysfunction‐associated steatotic liver disease (MASLD) and are at greater risk of liver‐related adverse events. Existing non‐invasive tools show limited diagnostic performance in this population.
Zhuolin Zhou   +5 more
wiley   +1 more source

Does anticoagulation therapy improve outcomes in severe heart failure with reduced ejection fraction? A systematic review: Anticoagulation in severe heart failure: a systematic review. [PDF]

open access: yesAnn Med Surg (Lond)
Kamal A   +14 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy